NB
REGN icon

NBT Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

NBT Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.9K Sell
157
-4
-2% -$2.72K 0.01% 443
2026
Q1 		$124K Buy
161
+29
+22% +$22.2K 0.01% 407
2025
Q4 		$102K Hold
132
– – 0.01% 430
2025
Q3 		$74.2K Hold
132
– – ﹤0.01% 460
2025
Q2 		$69.3K Sell
132
-30
-19% -$16.7K ﹤0.01% 464
2025
Q1 		$103K Hold
162
– – 0.01% 418
2024
Q4 		$115K Hold
162
– – 0.01% 416
2024
Q3 		$170K Buy
+162
New +$180K 0.01% 390

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

NBT Bank's REGN Position: Q2 2026 in Review

NBT Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 2.5% in Q2 2026, selling an estimated $2.72K and leaving 157 shares worth $97.9K. The position accounts for 0.01% of the portfolio, ranked #443.

NBT Bank first reported a position in REGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $170K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • NBT Bank held 157 shares of Regeneron Pharmaceuticals worth $97.9K as of Q2 2026.
  • NBT Bank sold 4 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.72K.
  • Regeneron Pharmaceuticals made up 0.01% of NBT Bank's portfolio in Q2 2026, its #443 holding.
  • NBT Bank first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • NBT Bank's Regeneron Pharmaceuticals position peaked at $170K in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on NBT Bank's 13F filing for Q2 2026, filed 29 Jul 2026.